Trials / Completed
CompletedNCT03116191
Trial of SK-1404 for Nocturia Due to Nocturnal Polyuria in Japanese Subjects
- Status
- Completed
- Phase
- Phase 2
- Study type
- Interventional
- Enrollment
- 125 (actual)
- Sponsor
- Sanwa Kagaku Kenkyusho Co., Ltd. · Industry
- Sex
- All
- Age
- 55 Years – 79 Years
- Healthy volunteers
- Not accepted
Summary
The purpose of this trial is to demonstrate efficacy of SK-1404 against placebo for the treatment of subjects with nocturia due to nocturnal polyuria, during 4 weeks of treatment.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | SK-1404 | 4 weeks of repeated administration of SK-1404 to the patients of nocturia |
| DRUG | Placebo | 4 weeks of repeated administration of Placebo to the patients of nocturia |
Timeline
- Start date
- 2017-02-23
- Primary completion
- 2017-12-15
- Completion
- 2017-12-15
- First posted
- 2017-04-14
- Last updated
- 2018-04-13
Locations
1 site across 1 country: Japan
Source: ClinicalTrials.gov record NCT03116191. Inclusion in this directory is not an endorsement.